UniPharma Co., Ltd.
6621
Rank in Stocks
#27818
UniPharma Co., Ltd. is a Taiwanese enterprise specializing in the distribution... UniPharma Co., Ltd. is a Taiwanese enterprise specializing in the distribution of pharmaceuticals, medical apparatus, and diagnostic kits. Its diagnostic portfolio encompasses various medical disciplines, including oncology, gynecology, orthopedics, neurology, anesthesiology, and cardiology. The company's offerings feature products such as Adept reduction solution, anesthetic injections (including bain, esmolol HCI, and naloxone), the Elisa DR-70 test for in-vitro tumor detection, and Fomeject antidote injections. Furthermore, UniPharma extends its services to include drug development, research and development, clinical studies, and marketing. Its client base includes major medical centers, regional hospitals, and local clinics. Founded in 1998, UniPharma is headquartered in Taipei, Taiwan.
Share Price
$0.37337447
Last synced: 2026-11-13
Market Cap
$13.26M
Change (1 day)
-1.40%
Change (1 year)
-6.44%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade UniPharma Co., Ltd. (6621)
Category
Healthcare
EPS for UniPharma Co., Ltd. (6621)
EPS as of June 2026 TTM: $-0.03
According to UniPharma Co., Ltd.'s latest financial reports, its current EPS (TTM) is $-0.03. At the end of 2025 the company had an EPS of $-0.04, a decrease compared to its 2024 EPS of $-0.02.
EPS history for UniPharma Co., Ltd. from 2013 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.03 | -14.00% |
| 2025 | $-0.04 | 70.42% |
| 2024 | $-0.02 | 7.04% |
| 2023 | $-0.02 | 237.29% |
| 2022 | $-0.01 | -92.25% |
| 2021 | $-0.08 | 36.14% |
| 2020 | $-0.06 | 135.86% |
| 2019 | $-0.02 | -46.74% |
| 2018 | $-0.04 | -303.20% |
| 2017 | $0.02 | 195.95% |
| 2016 | $0.01 | 89.74% |
| 2015 | 0.00 | -108.14% |
| 2014 | $-0.05 | -40.64% |
| 2013 | $-0.08 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.03 | -17,628.78% |
DE
|
|
| $6.01 | -17,564.53% |
DE
|
|
| $1.53 | -4,556.10% |
JP
|
|
| $3.66 | -10,739.53% |
CH
|
|
| $0.45 | -1,408.14% |
IL
|
Questions about UniPharma Co., Ltd.'s earnings per share (EPS)
What is UniPharma Co., Ltd.'s earnings per share (EPS)?
UniPharma Co., Ltd.'s earnings per share (EPS) over the last twelve months is $-0.03, as of Jun 2026.
What was UniPharma Co., Ltd.'s earnings per share (EPS) in 2025?
In 2025, UniPharma Co., Ltd.'s earnings per share (EPS) was $-0.04, compared with $-0.02 in 2024.
How has UniPharma Co., Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, UniPharma Co., Ltd.'s earnings per share (EPS) was highest in 2022 ($-0.01) and lowest in 2021 ($-0.08).
How does UniPharma Co., Ltd.'s earnings per share (EPS) compare with similar companies?
UniPharma Co., Ltd.'s earnings per share (EPS) ($-0.03) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.03.